Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
The US Food and Drug Administration recommended A/California/07/2009 (H1N1)pdm09 virus for use as a vaccine during the 2009-2010 influenza season.
The US Food and Drug Administration recommended A/California/07/2009 (H1N1)pdm09-like viruses for use as vaccines during the 2010-2011 influenza season.
The World Health Organization recommended influenza A/California/07/2009 (H1N1)pdm09-like viruses for use as vaccines during the 2010 Southern Hemisphere and the 2010-2011 Northern Hemisphere influenza seasons.
Temperature: 35°C
Recommendations for Infection: Inoculate SPF chicken embryonated eggs (intra-allantoic) at 9-11 days old. Dilute virus in D-PBS prior to inoculation.
Incubation: 2 days at 35°C in a humidified, non-CO2 atmosphere.
Influenza Research Database – Details for A/California/7/2009(H1N1)
National Center for Immunization and Respiratory Diseases, CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58(RR-10): 1-8, 2009. PubMed: 19713882
Fiore AE, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8): 1-62, 2010. PubMed: 20689501
WHO recommendations on the composition of influenza virus vaccines
